0
Articles |

Tumor Neutrophil Elastase Is Closely Associated With the Direct Extension of Non-small Cell Lung Cancer Into the Aorta

Jun-ichi Yamashita; Michio Ogawa; Michio Abe; Naoko Hayashi; Yuji Kurusu; Katsunobu Kawahara; Takayuki Shirakusa
Author and Funding Information

Affiliations: From the Department of Surgery II, Kumamoto University School of Medicine, Kumamoto, Japan,  From the Department of Surgery II, Fukuoka University School of Medicine, Fukuoka, Japan

Affiliations: From the Department of Surgery II, Kumamoto University School of Medicine, Kumamoto, Japan,  From the Department of Surgery II, Fukuoka University School of Medicine, Fukuoka, Japan


1997 by the American College of Chest Physicians


Chest. 1997;111(4):885-890. doi:10.1378/chest.111.4.885
Text Size: A A A
Published online

Abstract

Objective: Neutrophil elastase (NE) is the only neutral protease that is able to degrade insoluble elastin and other extracellular matrix constituents, and thus, may be involved in tumor invasion and metastasis. Using a highly specific and sensitive enzyme immunoassay (EIA), we recently demonstrated that immunoreactive (ir)-NE is produced by non-small cell lung cancer cell lines. We have measured the ir-NE concentration in non-small cell lung cancer tumor extracts and have evaluated its association with disease stage.

Methods: We measured the ir-NE concentration in 144 non-small cell lung cancer tumor extracts using EIA, which permits the rapid measurement of both the free and α1-protease inhibitor (α1-PI) complexed form of ir-NE. In 15 clinical T4 (cT4) patients, we also determined the concentration of free ir-NE in tumor extracts using a kit that detects only NE complexed with α1-PI and subtracting that value from the total NE concentration.

Results: ir-NE was detected in tumor extracts from 115 of 144 patients, ranging from 0.21 to 23.35 µg/100 mg protein. When the 144 specimens were grouped according to the clinical stage of disease, the ir-NE concentration (mean±SE) was significantly higher in those with cT4 disease (n=15; 7.90±1.88 µg/100 mg protein) than in those with cT1 (n=29; 1.27±0.27; p<0.001), cT2 (n=64; 1.18±0.17; p<0.001), or cT3 disease (n=26; 1.99±0.38; p<0.003). There was no significant association between the ir-NE concentration and cN-factor or any other clinical features. When the ir-NE concentration in the tumor extracts of the cT4 patients was compared with respect to the tumor invasion sites, the ir-NE level was significantly higher in those with surgical T4 (sT4) disease with aortic invasion (n=4; 17.4±3.10) than in those who were down-staged postoperatively (n=5; 4.9±1.33; p=0.005) or those with sT4 disease with involvement of other sites (n=6; 4.07±1.83; p=0.004). Similar results were observed for the free form of ir-NE.

Conclusions: These data suggest that NE may be involved in tumor progression of non-small cell lung cancer. Since the aorta is one of the richest sources of polymeric and insoluble elastin, this enzyme may play an active role in the direct extension of the tumor into the aorta.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543